David A. Barda

Aurora A Kinase Inhibition Is Synthetic Lethal with Loss of the <i>RB1</i> Tumor Suppressor Gene

Xueqian Gong, Jian Du, Stephen H. Parsons et al. · Cancer Discovery · 2018 · 233 citations

Life Sciences, Oncology, Pharmacology +17

LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms

Constance King, H. Bruce Diaz, Samuel McNeely et al. · Molecular Cancer Therapeutics · 2015 · 189 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s)

Michael P. Johnson, David A. Barda, Thomas C. Britton et al. · Psychopharmacology · 2005 · 154 citations

Medicine, Neuroscience, Pharmacology +17

Characterization and preclinical development of LY2603618: a selective and potent Chk1 inhibitor

Constance King, Henry Diaz, Darlene Barnard et al. · Investigational New Drugs · 2013 · 111 citations

Medicine, Medicinal Chemistry, Pharmacology +11

Progress toward Synthesis of Diazonamide A. Preparation of a 3-(Oxazol-5-yl)-4-trifluoromethylsulfonyloxyindole and Its Use in Biaryl Coupling Reactions

Edwin Vedējs, David A. Barda · Organic Letters · 2000 · 84 citations

Natural Sciences, Chemistry, Medicinal Chemistry +11